No abstract available
MeSH terms
-
Adenomatous Polyposis Coli / drug therapy*
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
-
Anticarcinogenic Agents / therapeutic use*
-
Arthritis / drug therapy
-
Celecoxib
-
Cyclooxygenase 2
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors / therapeutic use*
-
Drug Approval
-
Humans
-
Isoenzymes / pharmacology*
-
Membrane Proteins
-
Prostaglandin-Endoperoxide Synthases / pharmacology*
-
Pyrazoles
-
Sulfonamides / therapeutic use*
-
United States
-
United States Food and Drug Administration
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Anticarcinogenic Agents
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors
-
Isoenzymes
-
Membrane Proteins
-
Pyrazoles
-
Sulfonamides
-
Cyclooxygenase 2
-
PTGS2 protein, human
-
Prostaglandin-Endoperoxide Synthases
-
Celecoxib